Quick Comparison

Argireline (Acetyl Hexapeptide-3)Ferulic Acid
Typical ConcentrationTypically used at 5-10% concentration. Apply twice daily to expression line areas (forehead, around eyes, between brows). Effects visible after 2-4 weeks. Must be used continuously — effects reverse when stopped.Typically used at 0.5-1% in combination with vitamin C (15-20%) and vitamin E (1%). The Pinnell formulation (15% L-AA + 1% alpha-tocopherol + 0.5% ferulic acid at pH 3.0-3.5) is the standard. Apply in the morning under sunscreen.
ApplicationTopical (serum, cream). Water-soluble. Apply directly to expression line areas.Topical (serum, usually in combination with vitamins C and E). Apply in the morning.
Research Papers10 papers10 papers
Categories

Mechanism of Action

Argireline (Acetyl Hexapeptide-3)

Argireline (acetyl hexapeptide-3) mimics the C-terminal region of SNAP-25, a core SNARE complex component. The SNARE complex (SNAP-25, syntaxin, synaptobrevin) mediates vesicle fusion at the neuromuscular junction for acetylcholine release. Argireline competes with SNAP-25 for syntaxin binding, partially disrupting SNARE assembly and reducing neurotransmitter exocytosis. This decreases acetylcholine release and attenuates facial muscle contraction intensity. The effect is dose-dependent, localized, and reversible—unlike botulinum toxin's enzymatic cleavage of SNAP-25. Clinical studies show ~30% wrinkle reduction versus 80%+ with injectable neurotoxins. Provides non-invasive expression line softening.

Ferulic Acid

Ferulic acid is a hydroxycinnamic acid that scavenges free radicals (superoxide, hydroxyl, peroxyl) through its phenolic ring structure and conjugated double-bond system. When combined with vitamins C and E, it creates a synergistic antioxidant network: ferulic acid stabilizes L-ascorbic acid by preventing oxidation to dehydroascorbic acid, while the three compounds regenerate each other via redox cycling after neutralizing free radicals—extending the antioxidant capacity of the formulation. Ferulic acid absorbs UV light in the 290–330 nm range, providing direct photoprotection and reducing UV-induced DNA damage. It inhibits matrix metalloproteinase-1 (MMP-1, interstitial collagenase) expression, preventing UV-triggered collagen degradation. It also downregulates AP-1 and NF-κB signaling, reducing inflammatory mediators and UV-induced erythema. The landmark Pinnell formulation (15% L-AA + 1% alpha-tocopherol + 0.5% ferulic acid at pH 3.0–3.5) demonstrates these synergistic effects clinically.

Risks & Safety

Argireline (Acetyl Hexapeptide-3)

Common

Very well-tolerated. Occasional mild tingling.

Serious

None documented.

Rare

Allergic reaction. At very high concentrations, some users report a slight 'droopy' feeling in the treated area.

Ferulic Acid

Common

May contribute to slight stinging when combined with low-pH vitamin C serums.

Serious

None.

Rare

Contact allergy.

Full Profiles